• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺结核导致的延迟死亡:未被察觉的亚治疗药物水平。

Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels.

作者信息

Morehead R S

机构信息

Division of Pulmonary and Critical Care Medicine, University of Kentucky School of Medicine and Veterans Affairs Medical Center, Lexington, USA.

出版信息

South Med J. 2000 May;93(5):507-10.

PMID:10832953
Abstract

A patient with fulminant pulmonary tuberculosis died after 41 days of intensive care despite pansensitive organisms and no known underlying immunosuppression. Two factors leading to death in this patient were a delay in seeking medical attention and a subtherapeutic serum level of rifampin, though no obvious evidence of malabsorption existed. Malabsorption of antitubercular drugs is under-recognized and of extreme importance in the treatment of critically ill patients with active pulmonary tuberculosis. Factors associated with mortality from tuberculosis and selected aspects of critical care management are discussed.

摘要

一名暴发性肺结核患者在重症监护41天后死亡,尽管病原体对所有药物敏感且无已知的潜在免疫抑制。导致该患者死亡的两个因素是就医延迟和利福平血清水平未达到治疗剂量,尽管没有明显的吸收不良证据。抗结核药物吸收不良未得到充分认识,在重症活动性肺结核患者的治疗中极为重要。本文讨论了与结核病死亡率相关的因素以及重症监护管理的某些方面。

相似文献

1
Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels.肺结核导致的延迟死亡:未被察觉的亚治疗药物水平。
South Med J. 2000 May;93(5):507-10.
2
[Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].新发肺结核患者中结核分枝杆菌的耐药性
Probl Tuberk Bolezn Legk. 2005(12):37-9.
3
[Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].[社会适应良好患者耐药性肺结核治疗的长期结果]
Probl Tuberk Bolezn Legk. 2004(3):26-8.
4
Drug-resistance tuberculosis among the foreign-born in Canada.加拿大出生在国外者中的耐药结核病
Can Commun Dis Rep. 2005 Feb 15;31(4):46-52.
5
[Bactericidal therapy in patients with tuberculosis].[结核病患者的杀菌治疗]
Probl Tuberk Bolezn Legk. 2004(3):21-6.
6
[Considerations about the efficiency of treatment regimens with fixed Rifampicin-Isoniazid combinations in pulmonary tuberculosis].[关于利福平-异烟肼固定组合治疗方案在肺结核治疗中的疗效考量]
Pneumologia. 2004 Jan-Mar;53(1):23-5.
7
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.肺切除术联合基于异烟肼和利福平的药物治疗用于耐多药和广泛耐药结核病患者。
Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.
8
Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.基于脂质体的抗结核药物疗法在豚鼠结核病模型中的应用
Int J Antimicrob Agents. 2004 Apr;23(4):414-5. doi: 10.1016/j.ijantimicag.2004.01.002.
9
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.耐多药肺结核12个月治疗方案的结果
Int J Tuberc Lung Dis. 2002 Dec;6(12):1102-9.
10
[Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].[肺结核患者对利福平和异烟肼的同时耐药性]
Rev Mal Respir. 2000 Apr;17(2):477-80.

引用本文的文献

1
Determinants of serum concentration of first-line anti-tuberculosis drugs from China.中国一线抗结核药物血清浓度的决定因素
Medicine (Baltimore). 2019 Oct;98(41):e17523. doi: 10.1097/MD.0000000000017523.
2
Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery.大孔空心颗粒:肺部药物递送的轻质冠军。
Curr Pharm Des. 2016;22(17):2463-9. doi: 10.2174/1381612822666160128145356.
3
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.异烟肼、利福平、吡嗪酰胺和乙胺丁醇在印度儿童中的药代动力学
BMC Infect Dis. 2015 Mar 14;15:126. doi: 10.1186/s12879-015-0862-7.
4
Elucidating drug-enzyme interactions and their structural basis for improving the affinity and potency of isoniazid and its derivatives based on computer modeling approaches.基于计算机建模方法阐明异烟肼及其衍生物的药物-酶相互作用及其结构基础,以提高其亲和力和效力。
Molecules. 2010 Apr 16;15(4):2791-813. doi: 10.3390/molecules15042791.
5
Molecular fingerprinting reveals familial transmission of rifampin-resistant tuberculosis in Kuwait.分子指纹图谱揭示了科威特耐利福平结核病的家族传播情况。
Ann Saudi Med. 2005 Mar-Apr;25(2):150-3. doi: 10.5144/0256-4947.2005.150.